Mitil 5mg Tablet
PDF Leaflet Revision Date: 20 April 1977
Clinical Summary
Quick overview from the medicine insert
Indication
Control of mild to moderate mental and emotional disturbances, nausea, vomiting, and vertigo.
Dosage (summary)
5-10 mg 2-3 times daily for nausea; 20 mg for migraine; 12.5 mg twice daily for psychoses.
Special Populations
- Elderly
- Debilitated patients
- Children under 10 kg
Pregnancy & Breastfeeding
Safety not established; best avoided in pregnancy and lactation.
Key Drug Interactions
- CNS depressants may enhance effects
- Reduces antihypertensive action of guanethidine
- Increased risk of extrapyramidal effects with metoclopramide
Contraindications
- CNS depression or coma
- Bone marrow suppression
- Phaeochromocytoma
- Children under 10 kg
Common side effects
- Dry mouth
- Constipation
- Blurred vision
- Hypotension
- Extrapyramidal symptoms
Counselling Points
- Avoid alcohol and CNS depressants
- Caution when driving or operating machinery
- Regular eye examinations recommended
Serious warnings
- May cause drowsiness and impaired concentration
- Severe dystonic reactions in children
- Monitor haematological parameters in long-term use
Important Disclaimer
The Mitil 5mg Tablet professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
